ReviewAmerican journal of translational research2026
Clinical progress and prospects of biodegradable intestinal stents.
Review in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anastomotic leakage and stricture after colorectal surgery are severe complications in gastrointestinal surgery, with their incidence rates reaching as high as 5%-30% and 10%-20%, respectively. Traditional self-expanding metal stents (SEMS) have limited clinical applications due to such drawbacks as non-degradability and the requirement for secondary surgical removal. In recent years, biodegradable intestinal stents have become a research hotspot due to their temporary support and degradable properties. Among them, silk fibroin-based stents have stood out for their excellent biocompatibility and mechanical adaptability. This article systematically reviews the clinical indications, material classification, latest advances, clinical challenges, and prospects of degradable intestinal stents, and focuses on discussing the value of silk fibroin-based stents in preventing intestinal anastomotic leakage and stricture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.